knowledge -WSS

knowledge

author：comprehensive 2025-09-29 01:35:04 - browse：8628

ESMO signage in Madrid. — At ESMO 2023, antibody-drug conjugates were featured prominently. Andrew Joseph/STAT

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting, a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one). Multiple ADC studies were presented at the meeting’s top sessions. ADCs were, in short, the belle of the cancer research ball.

The thing is, ADCs are actually quite an old approach.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Pharma companies must ensure equitable access to obesity drugs

focus

WSS

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Study finds gene variants tied to breast cancer risk in Black women

FDA poised to publish guidelines for clinical trial diversity

Addressing health care workers' trauma can help fight burnout

Liver decline slowed by off

Wikipedia

knowledge

focus

At least 13 dead in Texas as scorching temps continue

Cigna wins case to block Amy Bricker's move to CVS

Activists slam private health insurers over coverage restrictions

For longer

Moonlake's readout produced a cash windfall. Risks remain

Addressing health care workers' trauma can help fight burnout

How one medical school became remarkably diverse

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Medical leaders decry Supreme Court decision on affirmative action

At flashy new research hub, AstraZeneca lays out ambitious growth goals

leisure time

H5N1 virus can be tracked in retail milk, scientists say

Curing rare childhood diseases will falter unless Congress steps up

Study: Why relieving medical debt did not improve financial outcomes

As a primary care physician, here's how I hope to partner with AI

NIH tests clinical research in primary care with $30 million program

H5N1 bird flu outbreak: Second human case reported, in Michigan

leisure time

focus

focus

explore